1 / 7

Endocrine Testing Market Trends 2019

The Global Endocrine Testing market was valued at USD 8.03 billion in 2018 and is expected to reach USD 15.09 billion by year 2026, at a CAGR of 8.1%. Endocrine testing involves examining urine or blood samples to detect the concentration of endocrinal hormones such as thyroid, diabetes, Cushing syndrome, etc.

thomasburnsrnd
Download Presentation

Endocrine Testing Market Trends 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Endocrine Testing Market To Reach USD 15.09 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com

  2. Market Summary Increasing incidence of diabetes, thyroid, sedentary lifestyle, increasing government support, growing healthcare awareness and obesity are key factors contributing to high CAGR of Endocrine Testing Market during forecast period. Market Size – USD 8.03 Billion in 2018, Market Growth - CAGR of 8.1%, Market Trends – Product launches and research for advanced and precise Endocrine Testing The Global Endocrine Testing market was valued at USD 8.03 billion in 2018 and is expected to reach USD 15.09 billion by year 2026, at a CAGR of 8.1%. Endocrine testing involves examining urine or blood samples to detect the concentration of endocrinal hormones such as thyroid, diabetes, Cushing syndrome, etc.

  3. Our Approach Market Summary Technological Advancements in terms of accuracy, affordability, cost-effectiveness, and introduction of easy-to-operate test kits have facilitated the penetration of home-based diagnostics. Key market players today are focusing on investing in launching innovative products, thereby increasing their market footprint in the endocrine testing market. Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth. Furthermore, a high prevalence of hyperthyroidism, hypothyroidism, and rising geriatric population are some of the key factors responsible for fueling market growth. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2240 Further key findings from the report suggest Various market players are engaged in developing new products. For instance, Helmholtz ZentrumMünchen allied with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes

  4. Our Approach Market Summary Sensors Segment is expected to witness lucrative growth with a CAGR of 8.6% during the forecast period As of 2018, Tandem Mass Spectrometry segment dominated the market with a market share of 33.9% and is expected to maintain its lead due to its increasing use in combination with liquid chromatography which aids in overcoming challenges associated with traditional techniques in Endocrine testing The Insulin test segment is expected to register fastest growth with a CAGR of 8.8% during the forecast period The thyroid Stimulating hormone (TSH) segment is prophesied to dominate the global Endocrine testing market with a share of 0% In the End-use, hospital users accounted for largest market share and is expected to be seen leading in the upcoming years The North American region dominated the global endocrine testing market in in terms of revenue generation with a share of 3% To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/endocrine-testing-market

  5. Our Approach Market Summary Key participants include AB Sciex, Abbott Laboratories, Beckman Coulter, bioMerieux SA, BioRad Laboratories, Biomedical Technologies, Agilent Technologies, Quest Diagnostics, Diasorin, Hoffmann- La Roche Ltd., Thermo Fisher Scientific, Quest Diagnostics and Siemens Healthineers. For the purpose of this report, Reports and Data has segmented the Endocrine Testing market on the basis of Test type, Technology type, End-use, and region: Test Type (Revenue, USD Million; 2016–2026) Estradiol TSH Insulin Cortisol FSH hCG LH Technology Type (Revenue, USD Million; 2016–2026) Tandem Mass Spectrometry Immunoassay Monoclonal & Polyclonal antibody technologies Sensor technology

  6. Our Approach Market Summary End Use (Revenue, USD Million; 2016–2026) Hospital Commercial Laboratory Ambulatory Care Centres Others Order Now: https://www.reportsanddata.com/checkout-form/2240 Regional Outlook (Volume, Kilo Tons and Revenue, USD Billion; 2016-2026) North America Europe Asia Pacific MEA Latin America

  7. Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com About Us Our Approach About Us

More Related